Pathfinder Bancorp reports Q1 2026 results today with short interest having nearly doubled in a month — an unusual move for a micro-cap community bank with otherwise placid positioning.
Short interest climbed 88% over the past month to reach roughly 9,750 shares, now representing about 0.20% of free float. That number is objectively small, but the pace of the move is striking for a stock this size. The one-day jump of 45% on April 28 alone pushed the ORTEX short score to 32.9 — its highest reading of the past two weeks. The borrow market remains loose: cost to borrow ticked up 46% over the week to 1.05%, and lending pool availability is ample, meaning new short positions face no squeeze friction. The overall picture is one of mild and growing caution from a small cohort of shorts, not a crowded structural bet.
The insider signal cuts the other way. Directors have been net buyers in recent months. Adam Gagas picked up roughly 1,956 shares across two trades in February at prices between $13.50 and $13.75, and David Ayoub added 425 shares at $12.83 in early February. Net insider activity over the past 90 days totalled approximately 4,246 shares bought, worth around $57,000. These are modest dollar amounts for any large institution, but for a bank with a float this concentrated, director-level purchases at prices close to today's $13.60 close carry more weight than the raw dollar figure suggests. Castle Creek Advisors holds 28.6% of shares, and Vanguard meaningfully added to its position in Q1, reporting a 95,262-share increase as of March 31 — a notable move for a passive manager in a stock this small.
On the historical earnings record, the pattern has leaned negative. The last four prints produced an average one-day decline, with the January 2026 event delivering a sharp 14.7% drop followed by a further 9.0% loss over five days. The subsequent print in late January saw a more contained 4.0% one-day move, though the five-day outcome was again negative at 9.5%. No analyst consensus or valuation data is current enough to inform the debate on fair value.
Today's print will test whether the bank's fundamentals justify the stock's 7% recovery over the past month — and whether the recent uptick in short interest reflects genuine concern about the Q1 numbers or simply noise in a thinly traded name.
See the live data behind this article on ORTEX.
Open PBHC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
